Renal uric acid clearance in human neonates

Insights

Infant uric acid clearance improves with gestational age, with fractional excretion of uric acid decreasing significantly. This developmental change in renal handling of uric acid may impact infant kidney health.

Area of Science:

  • Neonatal physiology
  • Pediatric nephrology
  • Uric acid metabolism

Background:

  • Uric acid homeostasis is critical in neonates.
  • Renal handling of uric acid in premature and term infants is not fully understood.
  • Gestational age significantly influences neonatal kidney function.

Purpose of the Study:

  • To investigate the renal clearance of uric acid in premature and term infants within the first 24 hours of life.
  • To determine the relationship between gestational age and uric acid excretion.
  • To explore the implications of uric acid handling for neonatal kidney health.

Main Methods:

  • Studied renal clearance of uric acid in 40 infants (premature and term) within 24 hours of birth.
  • Measured creatinine clearance and uric acid clearance in relation to gestational age.
  • Assessed fractional excretion of uric acid (FEUA) and its correlation with gestational age and postnatal development.

Main Results:

  • Uric acid clearance and creatinine clearance increased with gestational age.
  • Serum uric acid concentration and FEUA were inversely related to gestational age.
  • FEUA decreased from approximately 70% in very premature infants to 39% in term infants, indicating altered tubular transport.
  • FEUA also declined during early postnatal development in premature infants.

Conclusions:

  • Renal uric acid excretion undergoes significant maturation during late gestation and early postnatal life.
  • The observed decline in FEUA with advancing gestational age is linked to changes in renal tubular transport of uric acid.
  • High basal uric acid excretion in neonates may pose a risk for acute uric acid nephropathy under conditions of increased excretion demands.

Related Concept Videos

Renal Clearance01:23

Renal Clearance

The glomerular filtration rate (GFR) is a critical marker of kidney function, reflecting the efficiency of filtration by the glomeruli. Renal clearance of specific substances, such as inulin or creatinine, is commonly used to measure GFR.
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...